Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2025-12-24 @ 4:15 PM
NCT ID:
NCT00440466
Eligibility Criteria:
Inclusion Criteria:
* Meet the diagnostic criteria for chronic kidney disease, defined as a glomerular filtration rate (GFR) \>=15 mL/min per 1.73 m2 and \<60 mL/min per 1.73 m2 (Stages 3 and 4) as calculated by the central laboratory
* Hemoglobin level between 10.0 and 11.9 g/dL during the 4 weeks before randomization
* History of increase in hemoglobin after the initial dose
* Stable dose of epoetin alfa given once-weekly before randomization.
Exclusion Criteria:
* Uncontrolled hypertension
* Iron deficiency
* iron overload
* severe congestive heart failure
* Active infection
* Recent heart attack, Stroke or blood clot.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00440466
Study Brief:
Protocol Section:
NCT00440466